What Trump most favoured nation drug pricing policy might mean for Canadians

cbc.caPublished 09/27Open the original

By industry

Healthcare & Drug Pricing1 trading day+0.8%p15 stocks
“What Trump most favoured nation drug pricing policy might mean for Canadians”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/09/25	0.0%	0.0%
26/09/28	+0.1%	−0.8%
26/09/29	+0.0%	−0.8%
26/09/30	−1.2%	−0.9%
26/10/01	−1.6%	−0.9%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Kevin HernRepresentative · Republican · OK
Full saleUnitedhealth Group
Full sale
Unitedhealth Group
UNH
$15K–$50K
Joint
$15K–$50K
Reported 09/25
Traded 09/10
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.8M
12,000 sh
$1.8M
Filed 10/02
Traded 10/01
Pete SessionsRepresentative · Republican · TX
Full saleAbbVie
Full sale
AbbVie
ABBV
$15K–$50K
Self
$15K–$50K
Reported 09/18
Traded 09/14
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$445.9K
3,000 sh
$445.9K
Filed 10/02
Traded 10/01